LIMNW
Liminatus Pharma, Inc. Warrants
NASDAQ · Healthcare · Biotechnology · US
$0.06
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-4165.9%
Return on equity
-367.9%
Return on assets
-233.2%
Return on invested capital
0.00x
Asset turnover
-$4.0M
Cash from operations
$0.11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026